Biotest Pharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Biotest Pharmaceuticals Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12339
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biotest Pharmaceuticals Corp (Biotest Pharmaceuticals), a subsidiary of Biotest AG, is a manufacturer and distributor of of pharmaceutical and biotherapeutic products. The company offers products such as bivigam, nabi hb, hepatitis c immune globulin and plasma for further manufacturing. It offers services which include collection of source plasma and participates in the development of plasma protein products in the areas of primary immune deficiency and various hyperimmune products. The company develops products in the areas of humoral immunodeficiency, immunodeficiency, x-linked agammaglobulinemia, acute exposure to blood, perinatal exposure of infants, acute hbv infection, congenital agammaglobulinemia, wiskott-aldrich syndrome, combined immunodeficiencies. Biotest is headquartered in Boca Raton, Florida, the US.

Biotest Pharmaceuticals Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Biotest Pharma Enters into Distribution Agreement with Kedrion Biopharma 10
Licensing Agreements 11
Adma Biologics Enters Into Licensing Agreement With Biotest Pharma For RSV Immune Globulin 11
Equity Offering 12
ADMA Biologics Raises USD40 Million in Public Offering of Shares 12
Asset Transactions 14
ADMA Biologics Acquires Certain Assets from Biotest Pharma 14
Acquisition 16
Grifols Shared Services North America Acquires Biotest for USD286 Million 16
Biotest Pharmaceuticals Corp – Key Competitors 17
Biotest Pharmaceuticals Corp – Key Employees 18
Biotest Pharmaceuticals Corp – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Strategy And Business Planning 20
Sep 24, 2018: Grifols Announces the Opening of Biotest Pharmaceuticals Corporation’s Newest Plasma Donor Center in Bowling Green, Ohio 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Key Facts 2
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biotest Pharmaceuticals Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Biotest Pharma Enters into Distribution Agreement with Kedrion Biopharma 10
Adma Biologics Enters Into Licensing Agreement With Biotest Pharma For RSV Immune Globulin 11
ADMA Biologics Raises USD40 Million in Public Offering of Shares 12
ADMA Biologics Acquires Certain Assets from Biotest Pharma 14
Grifols Shared Services North America Acquires Biotest for USD286 Million 16
Biotest Pharmaceuticals Corp, Key Competitors 17
Biotest Pharmaceuticals Corp, Key Employees 18

List of Figures
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biotest Pharmaceuticals Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Biotest Pharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hera SpA (HER):企業の財務・戦略的SWOT分析
    Hera SpA (HER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Murphy Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Murphy Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Murphy Oil Corp (Murphy) is an international independent oil and gas exploration and production company. It explores for and produces crude oil, natural gas, and natural gas liquids. The company oper …
  • Corning Inc (GLW):電力:M&Aディール及び事業提携情報
    Summary Corning Inc (Corning) manufactures and sells ceramics, specialty glasses, and related materials. The company offers glass substrates, which find application in LCD televisions, computer monitors and laptops; optical fibers, cable, hardware and equipment for telecommunications networks; ceram …
  • Jadranski naftovod dd (JNAF-R-A):企業の財務・戦略的SWOT分析
    Summary Jadranski naftovod dd (JANAF Plc) is an oil pipeline system managing company that operates crude oil transportation system and reloading and storage of crude oil and oil products. The company manages janaf system, an international crude oil transportation system. Its janaf systems consists o …
  • Rousselot S.A.S.:企業の戦略・SWOT・財務情報
    Rousselot S.A.S. - Strategy, SWOT and Corporate Finance Report Summary Rousselot S.A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Petrobras Argentina SA:企業の戦略的SWOT分析
    Petrobras Argentina SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Culture Landmark Investment Ltd:企業の戦略・SWOT・財務分析
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Eloro Resources Ltd (ELO):企業の財務・戦略的SWOT分析
    Summary Eloro Resources Ltd (Eloro Resources) is a mining and minerals exploration and development company that offers mineral exploration and development services. The company acquires, explores and develops precious and base-metal resources properties across Quebec. It explores for titanium, silve …
  • Workspace Group Plc:企業の戦略・SWOT・財務情報
    Workspace Group Plc - Strategy, SWOT and Corporate Finance Report Summary Workspace Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • HAI Argochem (HAI):企業の財務・戦略的SWOT分析
    HAI Argochem (HAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Strong Petrochemical Holdings Ltd:企業の戦略・SWOT・財務情報
    Strong Petrochemical Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Strong Petrochemical Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Wintershall Holding GmbH:石油・ガス:M&Aディール及び事業提携情報
    Summary Wintershall Holding GmbH (Wintershall) explores for production of oil and natural gas. It operates as a subsidiary of BASF Group. The company holds expertise in conducting geological studies, geophysical measurements, seismic surveys, reservoir modeling, field development, onshore and offsho …
  • Netalogue Technologies plc (NTLP):企業の財務・戦略的SWOT分析
    Summary Netalogue Technologies plc (Netalogue) is a technology company that develops, markets and support e-procurement software systems. The company offers services such as e-commerce solutions, web design, hosting and e-marketing. It solutions include B2B Webstores, B2B/C webstores, B2corp, B2chan …
  • Ausgrid:企業の戦略的SWOT分析
    Ausgrid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Bostwick Laboratories Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bostwick Laboratories Inc (Bostwick) is a medical laboratory that focuses on the interpretation of prostate and urological biopsies. The company offers services such as client services, clinical services, urologic laboratory services, and subspecialty laboratory services. Its urologic labora …
  • Metalloinvest MC LLC:企業の戦略的SWOT分析
    Metalloinvest MC LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • NNEGC Energoatom:企業の戦略的SWOT分析
    NNEGC Energoatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Aiful Corporation:企業の戦略・SWOT・財務情報
    Aiful Corporation - Strategy, SWOT and Corporate Finance Report Summary Aiful Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Women’s Choice Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Women's Choice Pharmaceuticals LLC (WCP) is a pharmaceutical company that offers prescription products for women’s health care and urology markets. The company’s products include fem pH, a therapeutic vaginal jelly that is used to promote and maintain vaginal acidity caused by diabetes, horm …
  • Jardine Cycle & Carriage Ltd (C07):企業の財務・戦略的SWOT分析
    Jardine Cycle & Carriage Ltd (C07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆